Answers are grounded in this paper and cite their sources.
Design study of an injectable diagnostic and therapeutic-logic system made only of DNA strands, with no living cells. The circuit circulates inert and activates only inside cells presenting a two-marker disease signature via toehold exchange. Computed budgets cover activation (0.510 in a diseased cell, 3.66% total false activation in a healthy cell), clearance (4.36 h half-life, 14.5 h working window), and payload (35,075 copies per target cell against a 10,000-copy requirement), together with a quantitative safety comparison against living engineered-cell products and the costs of giving up replication, migration, and memory. SIMULATED, NOT MEASURED. Nothing described has been built, synthesized, or tested.
No takes yet. Share an insight, caveat, or question.
William Alexander Aldred (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: